We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GME:NYSEGameStop Corporation Analysis

Data as of 2026-04-06 - not real-time

$23.36

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

GameStop is trading at $23.36, essentially matching its DCF‑derived fair value of $23.34, and the latest quarter delivered an earnings beat despite a 14% revenue decline. Adjusted EPS of $0.77 surpassed expectations, while the company now sits on a $9 billion cash and short‑term investment war chest, bolstered by a $4.16 billion convertible debt issuance. Technical indicators are mixed: the 20‑day SMA (≈23.35) sits just above the 50‑day SMA, RSI hovers around the neutral 51 mark, and the MACD histogram is slightly negative, suggesting modest bearish pressure. Volume is trending upward, and the price is perched near the identified support at $22.03 with resistance around $25, leaving limited upside in the short run.
The broader picture is shaped by high 30‑day volatility (≈27%) and a low beta (≈0.57), reflecting a stock that swings sharply yet moves less than the market overall. The consumer‑cyclical sector exposure, combined with ongoing shifts toward digital distribution, adds medium‑to‑high sector risk. Recent headlines highlight speculation around a potential large‑scale acquisition, which could redeploy the cash reserve and re‑energize growth, but the lack of dividend and a negative free‑cash‑flow flow remain concerns. Investors should weigh the fair valuation and strong liquidity against the execution risk of any strategic pivot.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Earnings beat but revenue contraction
  • Technical bias slightly bearish (MACD, proximity to support)
  • Increasing volume indicating continued market interest

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Large cash reserve enabling strategic M&A
  • Fair valuation relative to DCF fair value
  • Potential upside from acquisition catalyst

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Industry shift toward digital distribution
  • Uncertainty around successful execution of transformation strategy
  • Balanced risk‑reward given solid balance sheet but modest growth outlook

Key Metrics & Analysis

Financial Health

Revenue Growth-13.90%
Profit Margin11.53%
P/E Ratio30.3
ROE8.07%
ROA2.19%
Debt/Equity80.12
P/B Ratio1.9
Op. Cash Flow$614.8M
Free Cash Flow$-159700000

Technical Analysis

TrendNeutral
RSI51.1
Support$22.03
Resistance$25.00
MA 20$23.35
MA 50$23.75
MA 200$23.13
MACDBearish
VolumeIncreasing
Fear & Greed Index78.8

Valuation

Fair Value$23.34
GradeFair
TypeValue

Risk Assessment

Beta0.57
Volatility27.17%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.